Rigel Pharmaceuticals (RIGL) Share-based Compensation Growth (5y) (2015 - 2025)
Rigel Pharmaceuticals (RIGL) Share-based Compensation Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.69% |
| Sep 30, 2025 | 55.81% |
| Jun 30, 2025 | -5.03% |
| Mar 31, 2025 | -1.80% |
| Dec 31, 2024 | -10.96% |
| Sep 30, 2024 | 77.37% |
| Jun 30, 2024 | -21.70% |
| Mar 31, 2024 | 40.95% |
| Dec 31, 2023 | -1.24% |
| Sep 30, 2023 | -58.31% |
| Jun 30, 2023 | -61.80% |
| Mar 31, 2023 | -78.16% |
| Dec 31, 2022 | 5.93% |
| Sep 30, 2022 | 25.40% |
| Jun 30, 2022 | -11.45% |
| Mar 31, 2022 | -0.32% |
| Dec 31, 2021 | 16.29% |
| Sep 30, 2021 | -30.70% |
| Jun 30, 2021 | -8.12% |
| Mar 31, 2021 | 7.84% |